ARCHIVES

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013